The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: UBS Upgrades GlaxoSmithKline To Buy From Sell

Fri, 13th Feb 2015 09:42

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thusday afternoon:
----------
FTSE 100
----------
UBS RAISES GLAXOSMITHKLINE TO 'BUY' ('SELL') - PRICE TARGET 1700 (1250) PENCE
----------
BERENBERG CUTS GLAXOSMITHKLINE PRICE TARGET TO 1560 (1620) PENCE - 'HOLD'
----------
BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1690 (1700) PENCE - 'OVERWEIGHT'
----------

Investec Places Rolls Royce Rating And Target Under Review From Hold At 860p

----------
DEUTSCHE BANK RAISES RIO TINTO PRICE TARGET TO 4400 (4333) PENCE - 'BUY'
----------
HSBC RAISES RIO TINTO PRICE TARGET TO 3490 (3380) PENCE - 'OVERWEIGHT'
----------
EXANE BNP RAISES RIO TINTO PRICE TARGET TO 3550 (3450) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES RIO TINTO PRICE TARGET TO 3550 (3400) PENCE - 'OVERWEIGHT'
----------
TRADERS: CS CUTS RIO TINTO TO 'NEUTRAL' ('OUTPERFORM') - PRICE TARGET 3400 PENCE
----------
S&P CAPITAL IQ RAISES RIO TINTO PRICE TARGET TO 3200 (2900) PENCE - 'HOLD'
----------
BERENBERG RAISES RECKITT BENCKISER PRICE TARGET TO 5900 (5600) PENCE - 'HOLD'
----------
LIBERUM RAISES RECKITT BENCKISER PRICE TARGET TO 6250 (6000) PENCE - 'BUY'
----------
BARCLAYS RAISES GKN PRICE TARGET TO 450 (390) PENCE - 'OVERWEIGHT'
----------
UBS RAISES SHIRE PRICE TARGET TO 5400 (5000) PENCE - 'BUY'
----------
BERNSTEIN RAISES UNITED UTILITIES TARGET TO 1050 (1010) PENCE - 'OUTPERFORM'
----------
SOCGEN RAISES WHITBREAD PRICE TARGET TO 5650 (5000) PENCE - 'BUY'
----------
SOCGEN RAISES INTERCONTINENTAL HOTELS TARGET TO 2700 (2300) PENCE - 'HOLD'
----------
NUMIS CUTS ITV TO 'ADD' ('BUY') - TARGET 260 PENCE
----------
DEUTSCHE BANK CUTS TULLOW OIL PRICE TARGET TO 370 (400) PENCE - 'HOLD'
----------
JEFFERIES RAISES EXPERIAN PRICE TARGET TO 1340 (1240) PENCE - 'BUY'
----------
FTSE 250
----------
Shore Capital Cuts ICAP To Hold From Buy, Price Target 468p
----------
JEFFERIES CUTS TALK TALK TO 'UNDERPERFORM' ('HOLD') - TARGET 260 PENCE
----------
BERENBERG RAISES INFORMA PRICE TARGET TO 530 (520) PENCE - 'HOLD'
----------
NOMURA RAISES INFORMA PRICE TARGET TO 600 (575) PENCE - 'BUY'
----------
EXANE BNP RAISES POUNDLAND GROUP PRICE TARGET TO 450 (400) PENCE - 'OUTPERFORM'
----------
PANMURE RAISES COMPUTACENTER PRICE TARGET TO 752 (728) PENCE - 'BUY'
----------
HSBC RAISES INMARSAT PRICE TARGET TO 930 (780) PENCE - 'NEUTRAL'
----------
JEFFERIES RAISES MILLENNIUM & COPTHORNE TARGET TO 570 (550) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
NUMIS RESUMES APR ENERGY WITH 'BUY' - TARGET 374 PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.